sector: Healthcare ·
industry: Pharmaceuticals - Diversified ·
As of
24 Nov 2009
167.40CHF
CHF167.40
24 Nov 2009
+0.72%
CHF166.20
CHF165.00
1,999,246
CHF168.20
CHF164.80
CHF174.70
CHF122.80
0.72
1,450,834
News
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Schwan, Severin |
Chairman of the Corporate Executive Committee, Chief Executive Officer |
5,283,340 |
| Humer, Franz |
Non-Executive Chairman of the Board of Directors |
11,080,000 |
| Gerber, Fritz |
Honorary Chairman of the Board |
-- |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
CHF143,357.91 |
| Shares Outstanding (Mil.) |
862.56 |
| Float (Mil.) |
722.24 |
| |
| Dividend Information |
| Yield % |
-- |
| Annual Dividend (CHF CHF) |
5.00 |
| Payout Ratio(TTM) % |
56.59 |
| |
| Financial Strength |
| Quick Ratio |
2.71 |
| Current Ratio |
1.49 |
| LT Debt/Equity |
1,136.92 |
| Total Debt/Equity |
1,536.21 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
18.75 |
| Price/Sales(TTM) |
3.01 |
| Price/Book(TTM) |
42.51 |
| Price/Cash Flow(TTM) |
12.06 |
| |
|
| Per Share Data |
| Earnings(TTM) |
CHF8.87 |
| Sales(TTM) |
CHF55.37 |
| Book Value(MRQ) |
CHF3.91 |
| Cash Flow(TTM) |
CHF13.83 |
| Cash(MRQ) |
CHF22.40 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
33.88 |
| Return on Assets(TTM) |
12.44 |
| Return on Investment(TTM) |
18.39 |
| |
|
| Margins |
| Gross Margin(TTM) % |
70.12 |
| Operating Margin(TTM) % |
25.57 |
| Profit Margin(TTM) % |
19.24 |
|
| |
|